Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gordon Sussman

Showing results (21-30 of 67) with videos related to

Pageof 7
Sort By:
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|January 29, 2014
Real-life experiences with omalizumab for the treatment of chronic urticariaGordon Sussman, Jacques Hébert, Carly Barron, et al.
Journal of Drugs in Dermatology : JDD|March 5, 2020
Multidisciplinary Real-World Experience With Bilastine, a Second Generation AntihistamineCharles W. Lynde, Gordon Sussman, Pierre-Luc Dion, et al.
The Journal of Allergy and Clinical Immunology|August 2, 2011
Sustained 3-year efficacy of pre- and coseasonal 5-grass-pollen sublingual immunotherapy tablets in patients with grass pollen-induced rhinoconjunctivitisAlain Didier, Margitta Worm, Friedrich Horak, et al.
The Journal of Allergy and Clinical Immunology|January 19, 2002
Natural rubber latex allergy after 12 years: recommendations and perspectivesB Lauren Charous, Carlos Blanco, Susan Tarlo, et al.
Journal of Cutaneous Medicine and Surgery|October 31, 2017
A Treatment Algorithm for Moderate to Severe Atopic Dermatitis in AdultsCharles W Lynde, Marc Bourcier, Melinda Gooderham, et al.
Journal of Cutaneous Medicine and Surgery|September 17, 2016
Review of Systemic Treatment Options for Adult Atopic DermatitisMelinda Gooderham, Charles W Lynde, Kim Papp, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|August 31, 2017
Management of chronic spontaneous urticaria (CSU): a treat to target approach using a patient reported outcomeHermenio Lima, Melinda Gooderham, Jan Dutz, et al.
International Immunopharmacology|August 2, 2003
Comparison of the efficacy of IGIV-C, 10% (caprylate/chromatography) and IGIV-SD, 10% as replacement therapy in primary immune deficiency. A randomized double-blind trialChaim M Roifman, Harry Schroeder, Melvin Berger, et al.
The Journal of Allergy and Clinical Immunology|August 28, 2016
A randomized trial of quilizumab in adults with refractory chronic spontaneous urticariaJeffrey M Harris, Christopher R Cabanski, Heleen Scheerens, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|June 29, 2013
Characterization of Cannabis sativa allergensAjay P Nayak, Brett J Green, Gordon Sussman, et al.
Pageof 7

Showing results (21-30 of 67) with videos related to

Sort By:
Pageof 7
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|January 29, 2014
Real-life experiences with omalizumab for the treatment of chronic urticariaGordon Sussman, Jacques Hébert, Carly Barron, et al.
Journal of Drugs in Dermatology : JDD|March 5, 2020
Multidisciplinary Real-World Experience With Bilastine, a Second Generation AntihistamineCharles W. Lynde, Gordon Sussman, Pierre-Luc Dion, et al.
The Journal of Allergy and Clinical Immunology|August 2, 2011
Sustained 3-year efficacy of pre- and coseasonal 5-grass-pollen sublingual immunotherapy tablets in patients with grass pollen-induced rhinoconjunctivitisAlain Didier, Margitta Worm, Friedrich Horak, et al.
The Journal of Allergy and Clinical Immunology|January 19, 2002
Natural rubber latex allergy after 12 years: recommendations and perspectivesB Lauren Charous, Carlos Blanco, Susan Tarlo, et al.
Journal of Cutaneous Medicine and Surgery|October 31, 2017
A Treatment Algorithm for Moderate to Severe Atopic Dermatitis in AdultsCharles W Lynde, Marc Bourcier, Melinda Gooderham, et al.
Journal of Cutaneous Medicine and Surgery|September 17, 2016
Review of Systemic Treatment Options for Adult Atopic DermatitisMelinda Gooderham, Charles W Lynde, Kim Papp, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|August 31, 2017
Management of chronic spontaneous urticaria (CSU): a treat to target approach using a patient reported outcomeHermenio Lima, Melinda Gooderham, Jan Dutz, et al.
International Immunopharmacology|August 2, 2003
Comparison of the efficacy of IGIV-C, 10% (caprylate/chromatography) and IGIV-SD, 10% as replacement therapy in primary immune deficiency. A randomized double-blind trialChaim M Roifman, Harry Schroeder, Melvin Berger, et al.
The Journal of Allergy and Clinical Immunology|August 28, 2016
A randomized trial of quilizumab in adults with refractory chronic spontaneous urticariaJeffrey M Harris, Christopher R Cabanski, Heleen Scheerens, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|June 29, 2013
Characterization of Cannabis sativa allergensAjay P Nayak, Brett J Green, Gordon Sussman, et al.
Pageof 7